Ovintiv (OVV)

NYSEEnergyOil & Gas Exploration & ProductionSnapshot 2026-10-23

$72.27+4.29%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Ovintiv’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+17.9% · beyond scale

+10% or more+5%0%−5%−10% or less

6.98 → 8.24 EPS · FY ending Dec 31, 2027 · 15 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 14 to 15; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	2.53B
EPS	—	2.328
Annual ending 2026-12-31
Revenue	—	10.2B
EPS	—	8.289
Annual ending 2027-12-31
Revenue	—	9.49B
EPS	—	8.237

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Full year capital investment between $2.25 and $2.35 billion	The company plans capital investment of $2.25 to $2.35 billion in 2026.	Intact	capital expenditure falls below $2.25 billion or exceeds $2.35 billion in FY26	Capital expenditures: $574M FY2026-Q2; GAAP. Published target: $2.25 to $2.35 billion. Target period is not explicitly aligned with this observation. Source published Jul 23, 2026574,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. The full year 2026 capital investment guidance has remained steady at $2.25 billion to $2.35 billion from 2025-Q4 through 2026-Q2. Second quarter 2026 capital expenditures were $574 million, near the midpoint of quarterly guidance. The trajectory shows consistent capital investment discipline, delivering on the stated plan. Delivery assessment Oct 24, 2026
Increase cash from operating activities to at least $1.056 billion	Valuation metrics like a 11.04 P/E and 3% free cash flow yield suggest value compared to peers.	Intact	cash from operating activities falls below $1 billion next year	Cash from operations: $1.632B FY2026-Q2; GAAP. Published target: >= $1.056 billion. Target period is not explicitly aligned with this observation. Source published Jul 23, 20261,632,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain quarterly dividend at $0.30 per share	It maintains a quarterly dividend of $0.30 per share, showing commitment to shareholders.	Intact	dividend per share falls below $0.30 next year	Dividend per share: $0.30 per share FY2026-Q2; GAAP. Published target: >= $0.30 per share. Target period is not explicitly aligned with this observation. Source published Jul 23, 20260.3 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 8451ff33-9d3a-467a-854e-2c23159593ff. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. The company consistently declared and paid a quarterly dividend of $0.30 per share from 2025-Q3 through 2026-Q2. This steady dividend payment reflects management's commitment to maintaining shareholder returns through dividends, delivering on this priority. Delivery assessment Oct 24, 2026
Achieve at least 1.8% revenue growth	A supporting condition in Ovintiv's published investment case. The stated target is >= 1.8% YoY.	Broken	revenue growth falls below 1.5% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$8.24

$6.99 → $8.24 · observed estimates

FY2027 revenue$9.49B

$8.94B → $9.49B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$6.99	$8,939,944,060	19 / 6
2026-07-25	$7.05	$8,973,683,050	19 / 8
2026-07-26	$7.05	$8,973,683,050	19 / 8
2026-07-27	$7.05	$9,014,433,050	19 / 8
2026-07-28	$6.84	$8,936,552,470	12 / 6
2026-07-29	$6.84	$8,936,552,470	12 / 6
2026-07-30	$7.30	$9,385,801,440	20 / 9
2026-07-31	$6.89	$9,124,144,352	13 / 7
2026-08-01	$6.89	$9,124,144,352	13 / 7
2026-08-02	$7.30	$9,385,801,440	20 / 9
2026-08-03	$7.30	$9,385,801,440	20 / 9
2026-08-04	$7.30	$9,385,801,440	20 / 9
2026-08-05	$7.31	$9,385,801,440	20 / 9
2026-08-06	$6.89	$9,124,144,352	13 / 7
2026-08-07	$6.89	$9,124,144,352	13 / 7
2026-08-08	$7.31	$9,385,801,440	20 / 9
2026-08-09	$7.31	$9,385,801,440	20 / 9
2026-08-10	$7.31	$9,385,801,440	20 / 9
2026-08-12	$6.89	$9,124,144,352	13 / 7
2026-08-13	$6.89	$9,124,144,352	13 / 7
2026-08-14	$6.89	$9,124,144,352	13 / 7
2026-08-15	$6.89	$9,124,144,352	13 / 7
2026-08-16	$6.89	$9,124,144,352	13 / 7
2026-08-17	$6.89	$9,124,144,352	13 / 7
2026-08-18	$6.89	$9,124,144,352	13 / 7
2026-08-19	$6.89	$9,124,144,352	13 / 7
2026-08-20	$6.97	$9,164,413,824	13 / 6
2026-08-21	$6.97	$9,164,413,824	13 / 6
2026-08-22	$6.97	$9,164,413,824	13 / 6
2026-08-23	$6.93	$9,164,413,824	13 / 6
2026-08-24	$6.93	$9,164,413,824	13 / 6
2026-08-25	$6.94	$9,225,002,059	13 / 6
2026-08-26	$6.94	$9,225,002,059	13 / 6
2026-08-27	$6.94	$9,225,002,059	13 / 6
2026-08-28	$6.94	$9,225,002,059	13 / 6
2026-08-29	$6.97	$9,225,002,059	13 / 6
2026-08-30	$6.97	$9,225,002,059	13 / 6
2026-08-31	$6.97	$9,225,002,059	13 / 6
2026-09-01	$6.97	$9,225,002,059	13 / 6
2026-09-02	$6.97	$9,225,002,059	13 / 6
2026-09-03	$6.97	$9,220,174,959	13 / 7
2026-09-04	$6.97	$9,152,387,461	13 / 7
2026-09-05	$6.97	$9,152,387,461	14 / 8
2026-09-06	$6.97	$9,152,387,461	15 / 8
2026-09-07	$6.95	$9,152,387,461	15 / 8
2026-09-08	$6.95	$9,152,387,461	15 / 8
2026-09-09	$6.95	$9,152,387,461	15 / 8
2026-09-10	$6.95	$9,152,387,461	15 / 8
2026-09-11	$6.91	$9,152,387,461	15 / 8
2026-09-12	$7.00	$9,185,720,794	15 / 8
2026-09-13	$7.00	$9,185,720,794	15 / 8
2026-09-14	$7.00	$9,185,720,794	15 / 8
2026-09-15	$6.99	$9,185,720,794	15 / 8
2026-09-16	$6.99	$9,185,720,794	15 / 8
2026-09-17	$6.99	$9,185,720,794	15 / 8
2026-09-18	$6.99	$9,185,720,794	15 / 8
2026-09-19	$6.99	$9,185,720,794	15 / 8
2026-09-20	$6.99	$9,185,720,794	15 / 8
2026-09-21	$6.99	$9,185,720,794	15 / 8
2026-09-22	$6.99	$9,185,720,794	15 / 8
2026-09-23	$6.98	$9,180,670,794	14 / 7
2026-09-24	$6.98	$9,180,670,794	14 / 7
2026-09-25	$7.03	$9,180,670,794	14 / 7
2026-09-26	$7.10	$9,209,340,833	14 / 7
2026-09-27	$7.10	$9,209,340,833	15 / 7
2026-09-28	$7.10	$9,209,340,833	15 / 7
2026-09-29	$7.10	$9,209,340,833	15 / 7
2026-09-30	$7.10	$9,209,340,833	15 / 7
2026-10-01	$7.14	$9,227,764,833	15 / 7
2026-10-02	$7.14	$9,227,764,833	15 / 7
2026-10-03	$7.19	$9,237,431,500	15 / 7
2026-10-04	$7.29	$9,237,431,500	15 / 7
2026-10-05	$7.29	$9,237,431,500	15 / 7
2026-10-06	$7.30	$9,237,431,500	15 / 7
2026-10-07	$7.30	$9,237,431,500	15 / 7
2026-10-08	$7.30	$9,237,431,500	15 / 7
2026-10-09	$7.30	$9,237,431,500	15 / 8
2026-10-10	$7.30	$9,237,431,500	15 / 8
2026-10-11	$7.54	$9,277,042,611	15 / 8
2026-10-12	$7.54	$9,277,042,611	15 / 8
2026-10-13	$7.55	$9,290,156,433	15 / 8
2026-10-14	$7.68	$9,342,573,099	14 / 7
2026-10-15	$7.69	$9,340,031,861	14 / 7
2026-10-16	$7.81	$9,377,976,305	14 / 7
2026-10-17	$7.81	$9,377,976,305	14 / 7
2026-10-18	$7.80	$9,377,976,305	15 / 7
2026-10-19	$7.80	$9,377,976,305	15 / 7
2026-10-20	$7.97	$9,377,976,305	15 / 7
2026-10-21	$8.09	$9,420,531,861	15 / 7
2026-10-22	$8.09	$9,420,531,861	15 / 7
2026-10-23	$8.09	$9,420,531,861	15 / 7
2026-10-24	$8.24	$9,488,542,972	15 / 7

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	19	6
2026-06-01	20	5
2026-07-01	20	4
2026-08-01	20	4
2026-09-01	22	5
2026-10-01	22	6

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 22 Buy / Strong Buy · 6 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades8 maintains

Recent actions · Sep 25–Oct 24 · 8 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Roth CapitalOct 22 · prior Jun 24

$55.00 → $65.00+18.2%

ScotiabankOct 19 · prior Oct 2

$75.00 → $80.00+6.7%

Morgan StanleyOct 15 · prior Aug 19

$67.00 → $71.00+6.0%

Wells FargoOct 14 · prior Sep 2

$79.00 → $82.00+3.8%

Truist FinancialOct 12 · prior Jul 27

$73.00 → $77.00+5.5%

CIBCOct 9

$75.00New observation · no comparable prior

$0$45.10$90.20

5 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Full year capital investment between $2.25 and $2.35 billionCapital expenditures: $574M
Increase cash from operating activities to at least $1.056 billionCash from operations: $1.632B
Maintain quarterly dividend at $0.30 per shareDividend per share: $0.30 per share
Achieve at least 1.8% revenue growthPublished status: Broken

Next proof point

Nov 3, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.3%Typical daily move · historical

Downside history

-17.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Ovintiv outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a cyclical energy business, where results can shift with sector conditions, alongside a production-growth and capital-discipline thesis. The long-term thesis is on watch: production is close to guidance and spending plans remain steady, but recent financial performance is weak and management execution has been volatile.

What's priced into Ovintiv

The valuation evidence is mixed: OVV is tagged as stretched and carries a sizable premium to peers, while one valuation measure says it is cheap versus peers. The expectations gap is modest, and the snapshot suggests the main source of vulnerability is a turbulent sector regime rather than a combination of expensive valuation, weak results, and sector turbulence.

What the fundamentals likely do

Near term, consecutive earnings misses, including the latest quarter, make another guidance cut an important risk, though the stated miss risk is low. For the multi-year view, second-quarter production was near the low end of guidance, while the company maintained its 2026 production range and capital plan; the quarterly dividend also remained steady.

What Ovintiv hinges on

The next call is a key test: a guidance cut could reinforce concerns about execution, while delivery against production and spending plans would support the operating case. Sector conditions also matter: continued strong results and higher guidance from COP, EOG, and OXY could sustain the energy-sector tailwind, while misses or lower guidance could weaken it.